Ad
EDIT Short Information Editas Medicine Inc.
home / stock / edit / edit short
Short Information | Editas Medicine Inc. (NASDAQ:EDIT)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 10,167,617 |
| Total Actual Volume | 48,060,049 |
| Short Trends | |
|---|---|
| Cover Days | 19 |
| Short Days | 0 |
| No Change Days | 1 |
| Averages | |
|---|---|
| Average Short Volume | 508,381 |
| Average Short Percentage | 23.00% |
Is there a EDIT Short Squeeze or Breakout about to happen?
See the EDIT Short Analysis for free Sign up or Login
Powered by Squeeze Report
EDIT Twenty Trading Day's Volume to Short Volume Chart
EDIT Twenty Trading Day Price Chart
EDIT Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 06-20-2025 | $2.34 | $2.22 | $2.385 | $2.15 | 3,059,982 | 523,036 | 17.09% |
| 06-18-2025 | $2.17 | $2.35 | $2.38 | $2.05 | 3,586,557 | 478,872 | 13.35% |
| 06-17-2025 | $2.31 | $2.14 | $2.55 | $2.1 | 5,458,992 | 776,053 | 14.22% |
| 06-16-2025 | $2.005 | $2.16 | $2.2 | $1.935 | 2,832,805 | 305,607 | 10.79% |
| 06-13-2025 | $2.02 | $1.97 | $2.1152 | $1.94 | 3,051,468 | 845,217 | 27.7% |
| 06-12-2025 | $2.05 | $2.18 | $2.295 | $1.9706 | 3,205,125 | 523,797 | 16.34% |
| 06-11-2025 | $2.1 | $2.03 | $2.19 | $2.0125 | 2,013,087 | 447,002 | 22.2% |
| 06-10-2025 | $1.98 | $2.1 | $2.23 | $1.92 | 2,880,371 | 571,422 | 19.84% |
| 06-09-2025 | $1.98 | $1.93 | $2.02 | $1.845 | 1,222,385 | 223,567 | 18.29% |
| 06-06-2025 | $1.81 | $1.91 | $1.97 | $1.8 | 2,451,101 | 439,566 | 17.93% |
| 06-05-2025 | $1.8 | $1.8 | $1.98 | $1.73 | 3,177,198 | 856,637 | 26.96% |
| 06-04-2025 | $1.82 | $1.82 | $1.85 | $1.77 | 866,163 | 280,910 | 32.43% |
| 06-03-2025 | $1.75 | $1.82 | $1.87 | $1.66 | 1,658,560 | 405,131 | 24.43% |
| 06-02-2025 | $1.76 | $1.77 | $1.92 | $1.75 | 2,166,579 | 567,485 | 26.19% |
| 05-30-2025 | $1.8 | $1.72 | $1.81 | $1.7 | 1,276,156 | 305,600 | 23.95% |
| 05-29-2025 | $1.89 | $1.83 | $1.9499 | $1.765 | 1,557,326 | 352,561 | 22.64% |
| 05-28-2025 | $1.66 | $1.87 | $1.9 | $1.6 | 2,735,348 | 759,686 | 27.77% |
| 05-27-2025 | $1.59 | $1.65 | $1.785 | $1.5646 | 2,523,307 | 667,408 | 26.45% |
| 05-23-2025 | $1.54 | $1.55 | $1.59 | $1.51 | 952,670 | 330,127 | 34.65% |
| 05-22-2025 | $1.485 | $1.62 | $1.625 | $1.485 | 1,384,869 | 507,933 | 36.68% |
News, Short Squeeze, Breakout and More Instantly...
Editas Medicine Inc. Company Name:
EDIT Stock Symbol:
NASDAQ Market:
0.43% G/L:
$2.22 Last:
3,059,982 Volume:
$2.34 Open:
$2.22 Close:
Editas Medicine Inc. Website:
Ad
-
2025-06-17 10:07:00 ET The biotechnology sector is a thrilling arena for investors, with a history of delivering groundbreaking medical innovations that have led to massive shareholder returns. Editas Medicine (NASDAQ: EDIT) is a promising clinical-stage company that has captured Wa...
-
Achieved 58% mean editing at five months after a single dose using high efficiency HSC delivery, demonstrating therapeutically relevant editing levels using a clinically validated strategy. Achievement supports development of a novel, in vivo approach to treating sickle cell disease a...
-
2025-05-25 06:00:00 ET Over the past few years, investors have moved away from somewhat speculative and unprofitable companies to put their money into safer, steadier investments. Editas Medicine (NASDAQ: EDIT) , a gene-editing-focused clinical-stage biotech, is firmly in the specul...